ERBB3 and breast carcinoma: In keeping with our results, studies on breast cancer investigating the expression of the individual EGF receptors also show that increased HER3 and HER4 expression appears to be associated with better prognosis (Quinn et al, 1994; Knowlden et al, 1998).